<< Back To Home

Outcomes for girls without HPV vaccination in Japan

Wednesday, 3rd of August 2016 Print

The Lancet Oncology, Volume 17, No. 7, p868–869, July 2016


Outcomes for girls without HPV vaccination in Japan

Yusuke Tanaka, 

Yutaka UedaPress enter key to Email the author

Tomomi Egawa-Takata, 

Asami Yagi, 

Kiyoshi Yoshino, 

Tadashi Kimura


Abstract below; full text is available to journal subscribers.

In Japan, HPV vaccinations became available to girls aged 13–16 years with public aid from 2010 and subsequently became routine for those aged 12–16 years from April, 2013. However, in the spring late spring of 2013, the media repeatedly reported adverse events which were attributed to the HPV vaccination (including pain and motor disability) even though it is not exactly known whether these effects were actually caused by the vaccine. The Japanese Ministry of Health, Labour, and Welfare suspended its active recommendation for girls to receive HPV vaccinations in June, 2013.